Effects of alpha-casozepine (Zylkene) versus selegiline hydrochloride (Selgian, Anipryl) on anxiety disorders in dogs

References 

1. Beata C, Beaumont-Graff E, Coll V, Cordel J, Marion M, Massal N, et al. Effect of alpha-casozepine (Zylkene) on anxiety in cats. J. Vet. Behav. Clin. Appl. Res. 2007;2:40–46
2. Beata, C., Lefranc-Millot, C., Desor, D., 2005. Lactium®: a new anxiolytic product coming from milk. In: Mills, E.L.D., Landsberg, G., Horwitz, D., Duxbury, M., Mertens, P., Meyer, K., Radosta-Huntley, L., Reich, M., Willard, J. (Eds.), Proceedings of Current Issues and Research in Veterinary Behavioral Medicine. Minneapolis, MN, pp. 150-154.
3. Clarke AS, Kraemer GW, Kupfer DJ. Effects of rearing condition on HPA axis response to fluoxetine and desipramine treatment over repeated social separations in young rhesus monkeys. Psychiatry Res. 1998;2:91–104
4. Couture, A., 2001. La maladie mitrale et les troubles du comportement, (in French) Unpublished. Memoir for the diploma of behaviorist veterinarian GFNVS. p. 62.
5. Dodman N, Shuster L. Psychopharmacology of Animal Behavior Disorders. Malden, MA: Blackwell Science; 1998;
6. Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J. Dermatol. Sci. 1997;1:63–67
7. Kitani K, Minami C, Isobe K, Maehara K, Kanai S, Ivy GO, et al. Why L-deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects. Mech. Ageing Dev. 2002;8:1087–1100
8. Landsberg G. Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;3:471–479
9. Lanoir D, Canini F, Messaoudi M, Lefranc-Millot C, Demagny B, Martin S, et al. Long term effects of a bovine milk alpha-s1 casein hydrolysate on healthy low and high stress responders. Stress. 2002;5(suppl.):124
10. Levenstein S. Peptic ulcer at the end of the 20th century: biological and psychological risk factors. Can. J. Gastroenterol. 1999;9:753–759
11. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig. Dis. Sci. 1993;9:1581–1589
12. Loo H, Zarifian E, Boulenger JP, Davy JP. [Psychotropic drugs. The drugs to prescribe]. Rev. Prat. 1990;11:1043–1064
13. Marion, M., 2002. Contribution à l'étude du lien entre les troubles gastriques chroniques et l'anxiété chez le chien. (in French). Unpublished. Memoir for the diploma of behaviorist veterinarian GFNVS. p. 45.
14. Mege C. Dermatoses liées à des troubles du comportement chez le chat (in French). Unpublished. Memoir for the diploma of dermatology. Lyon, France: National Veterinary School of Lyon; 1997;p. 65
15. Mege, C., Beata, C., Beaumont-Graff, E., Diaz, C., Habran, T., Marlois, N., Muller, G., 2003. Pathologie Comportementale du Chien Masson-Pmcac, Paris, France, pp. 277-279.
16. Messaoudi, M., Bresson, J.-L., Desor, D., Lefranc-Millot, C., Boudier, J.-F., Paquin, P., 2002. Anxiolytic-like effects of the milk protein hydrolysate Prodiet F200 in healthy human volunteers. Stress. p. 124.
17. Messaoudi M, Lefranc-Millot C, Desor D, Demagny B, Bourdon L. Effects of a tryptic hydrolysate from bovine milk alpha(S1)-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. Eur. J. Nutr. 2005;2:128–132
18. Miclo L, Perrin E, Driou A, Papadopoulos V, Boujrad N, Vanderesse R, et al. Characterization of alpha-casozepine, a tryptic peptide from alpha-s1 casein with benzodiazepine-like activity. FASEB J. 2001;15:1780–1782
    • MEDLINE
19. Mills DS, Gandia Estelles M, Coleshaw PH, Shorthouse C. Retrospective analysis of the treatment of firework fears in dogs. Vet. Rec. 2003;18:561–562
20. Overall KL. Clinical Behavioral Medicine for Small Animals. St. Louis, MO: Mosby; 1997;pp. 209-212
21. Pageat, P., 1995. Pathologie du comportement du chien. Editions du Point Vétérinaire, Maisons-Alfort, pp. 204-220.
22. Pageat, P., 1998. Pathologie du comportement du chien. Editions du Point Vétérinaire, Maisons-Alfort, pp. 208-224.
23. Pageat, P., 2005. Assessing prolactinaemia in anxious dogs (Canis familiaris): interest in diagnostic value. In: Mills, D., Levine, E., Landsberg, G., Horwitz, D., Duxbury, M.M., Mertens, P., Meyer, K., Radosta-Huntley, L., Reisch, M., Willard, J. (Eds.), Proceedings of Current Issues and Research in Veterinary Behavioral Medicine, Minneapolis, MN, pp. 155-160.
24. Pageat P, Gaultier E. Current research in canine and feline pheromones. Vet. Clin. North Am. Small Anim. Pract. 2003;2:187–211
25. Pedersen HD, Koch J, Poulsen K, Jensen AL, Flagstad A. Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J. Vet. Intern. Med. 1995;5:328–331
26. Ruehl WW, Neilson J, Hart B, Head E, Bruyette DS, Cummings BJ. Therapeutic actions of L-deprenyl in dogs: a model of human brain aging. Adv. Pharmacol. 1998;42:316–319
    • MEDLINE
    • CrossRef
27. Schroeder H, Violle N, Messaoudi M, Lefranc-Millot C, Nejdi A, Demagny B, et al. Effects of ING-911, a tryptic hydrolysate from bovine milk alpha-S1casein on anxiety of Wistar male rats measured in the conditioned defensive burying (CDB) paradigm and the elevated plus maze test. Behav. Pharmacol. 2003;S1:31
28. Tamam L, Ozpoyraz N, San M, Bozkurt A. Association between idiopathic mitral valve prolapse and panic disorder. Croat. Med. J. 2000;4:410–416
29. Tancer ME, Stein MB, Bessette BB, Uhde TW. Behavioral effects of chronic imipramine treatment in genetically nervous pointer dogs. Physiol. Behav. 1990;1:179–181
30. Toren P, Eldar S, Cendorf D, Wolmer L, Weizman R, Zubadi R, et al. The prevalence of mitral valve prolapse in children with anxiety disorders. J. Psychiatr. Res. 1999;4:357–361
31. Uhde TW, Malloy LC, Slate SO. Fearful behavior, body size, and serum IGF-I levels in nervous and normal pointer dogs. Pharmacol. Biochem. Behav. 1992;1:263–269
32. Vienet-Legué, D., 2006. Evaluation de l'effet d'un collier DAP sur le comportements de chiots (Canis familiaris) lors de leur séjour en animalerie et après adoption. Etude randomisée en groupes parallèles contre placebo. Unpublished. Memoire pour le diplome de vétérinaire comportementaliste;. Ecole Nationale Vétérinaire d'Alfort, p. 30.
33. Violle N, Messaoudi M, Lefranc-Millot C, Desor D, Nejdi A, Demagny B, et al. Ethological comparison of the effects of a bovine alpha(s1)-casein tryptic hydrolysate and diazepam on the behavior of rats in two models of anxiety. Pharmacol. Biochem. Behav. 2006;3:517–523
34. Virga V. Behavioral dermatology. Vet. Clin. North Am. Small Anim. Pract. 2003;2:231–251
35. Yang S, Tsai TH, Hou ZY, Chen CY, Sim CB. The effect of panic attack on mitral valve prolapse. Acta Psychiatr. Scand. 1997;6:408–411